Literature DB >> 7747570

Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.

C B Engler1, B Sander, M Larsen, P Dalgaard, H Lund-Andersen.   

Abstract

Inward and outward movement of flourescein across the human blood-retina barrier was studied in five healthy volunteers, using a differential spectrofluorometry method that eliminates the contribution of fluorescein glucuronide to the total fluorescence in the vitreous and in plasma. The inward permeability across the blood-retina barrier, which is presumed to be passive, and the diffusion coefficient in the vitreous for fluorescein was calculated from data obtained 1 h after intravenous injection of fluorescein. The rate of elimination of fluorescein from the vitreous across the blood-retina barrier was estimated from data obtained 7 to 12 h after injection of fluorescein. The calculations were based upon the free plasma fluorescein decay curve and the preretinal fluorescein gradient in the vitreous. The mean inward permeability of fluorescein was 1.39 x 10(-7) cm/sec (range: 0.70-2.06 x 10(-7) cm/sec), whereas the mean outward permeability was 1.51 x 10(-5) cm/sec (range: 1.14-1.73 x 10(-5) cm/sec). We have thus found that the movement of fluorescein across the blood-retina barrier is highly asymmetric, the outward transport being more than 100 times faster than the passive inward leakage. This could indicate the presence of an active pumping mechanism in the blood-retina barrier, responsible for fluorescein transport in the direction from the vitreous to the blood.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7747570     DOI: 10.1111/j.1755-3768.1994.tb04675.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  9 in total

1.  Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor.

Authors:  Matthew S Stay; Jing Xu; Theodore W Randolph; Victor H Barocas
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

2.  Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.

Authors:  Ram K Balachandran; Victor H Barocas
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

3.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

4.  Increased serum proteins in non-exudative AMD retinas.

Authors:  Hannah Schultz; Ying Song; Bailey H Baumann; Rebecca J Kapphahn; Sandra R Montezuma; Deborah A Ferrington; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2019-05-31       Impact factor: 3.467

5.  Passive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARM.

Authors:  B Moldow; M Larsen; B Sander; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

6.  Transient transport across an inhomogeneous blood-retina barrier.

Authors:  P Dalgaard
Journal:  J Math Biol       Date:  1995       Impact factor: 2.259

7.  Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.

Authors:  B Sander; M Larsen; C Engler; C Strøm; B Moldow; N Larsen; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

8.  Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier.

Authors:  B Sander; M Larsen; C Engler; B Moldow; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

9.  Isotope-coded protein label based quantitative proteomic analysis reveals significant up-regulation of apolipoprotein A1 and ovotransferrin in the myopic chick vitreous.

Authors:  Feng-Juan Yu; Thomas Chuen Lam; Long-Qian Liu; Rachel Ka-Man Chun; Jimmy Ka-Wai Cheung; King-Kit Li; Chi-Ho To
Journal:  Sci Rep       Date:  2017-10-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.